Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
暂无分享,去创建一个
Ernest Frimpong Asamoah | James R Hurley | L. Dauer | J. Brierley | I. Mcdougall | C. Edinboro | A. Avram | J. Sisson | M. Milas | Lawrence T Dauer | Jason A Wexler | Anca M Avram | Mira Milas | James D Brierley | Carol Greenlee | James C Sisson | John Freitas | Iain Ross McDougall | Charlotte H Edinboro | David Rosenthal | Michael J Thomas | Ernest Asamoah | J. Wexler | J. Hurley | C. Greenlee | J. Freitas | David S Rosenthal | David S. Rosenthal | James D. Brierley | Anca M. Avram | Mira Milas | I. McDOUGALL | James C Sisson | John Freitas | James R Hurley | David Rosenthal | Michael J Thomas | Jason A Wexler | Ernest Asamoah | Carol Greenlee
[1] L. Bartalena. Diagnosis and management of Graves disease: a global overview , 2013, Nature Reviews Endocrinology.
[2] C. Edinboro,et al. Current safety practices relating to I-131 administration for diseases of the thyroid: a survey of physicians and allied practitioners. , 2011, Thyroid : official journal of the American Thyroid Association.
[3] Markus Luster,et al. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] A. Sawka,et al. Controversies in primary treatment of low-risk papillary thyroid cancer , 2013, The Lancet.
[5] H. Palmedo,et al. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[6] Jack Valentin,et al. Release of patients after therapy with unsealed radionuclides , 2004, Annals of the ICRP.
[7] F. Azizi,et al. Breastfeeding and maternal and infant iodine nutrition , 2009, Clinical endocrinology.
[8] J. Sisson. Response to Beasley CW, Moore WH, and Wagner LK , 2011 .
[9] M. Mcdermott,et al. New American Thyroid Association and American Association of Clinical Endocrinologists guidelines for thyrotoxicosis and other forms of hyperthyroidism: significant progress for the clinician and a guide to future research. , 2011, Thyroid : official journal of the American Thyroid Association.
[10] R. Kloos. Survey of radioiodine therapy safety practices highlights the need for user-friendly recommendations. , 2011, Thyroid : official journal of the American Thyroid Association.
[11] L. Wagner,et al. Release instructions for hyperthyroid patients treated with I-131. , 2011, Thyroid : official journal of the American Thyroid Association.
[12] H A Risch,et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. , 1989, The New England journal of medicine.
[13] M. Brzozowska,et al. Timing and Potential Role of Diagnostic I-123 Scintigraphy in Assessing Radioiodine Breast Uptake Before Ablation in Postpartum Women With Thyroid Cancer: A Case Series , 2006, Clinical nuclear medicine.
[14] A. Holmes,et al. ABM Clinical Protocol #5: Peripartum breastfeeding management for the healthy mother and infant at term, revision 2013. , 2013, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.
[15] Shannon D. Sullivan,et al. Thyroid disorders during pregnancy. , 2012, The Medical clinics of North America.
[16] J. Siegel,et al. LICENSEE OVER-RELIANCE ON CONSERVATISMS IN NRC GUIDANCE REGARDING THE RELEASE OF PATIENTS TREATED WITH 131I , 2007, Health physics.
[17] K. Gulenchyn,et al. Radiation exposure for 'caregivers' during high-dose outpatient radioiodine therapy. , 2007, Radiation protection dosimetry.
[18] D. Gnepp,et al. Pediatric thyroid cancer after the chernobyl disaster. Pathomorphologic study of 84 cases (1991–1992) from the republic of Belarus , 1994, Cancer.
[19] C. Buchpiguel,et al. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe? , 2009, Nuclear medicine communications.
[20] J. N. van den Anker,et al. Safety during breastfeeding: drugs, foods, environmental chemicals, and maternal infections. , 2013, Seminars in fetal & neonatal medicine.
[21] Stephanie L. Lee. Radioactive iodine therapy , 2012, Current opinion in endocrinology, diabetes, and obesity.
[22] J. Moake,et al. This article has been cited by other articles , 2003 .
[23] E. Mazzaferri. Empiric Radioactive Iodine Dosing Regimens Frequently Exceed Maximum Tolerated Activity Levels in Elderly Patients with Thyroid CancerTuttle RM, Leboeuf R, Robbins RJ, et al (Mem Sloan-Kettering Cancer Ctr, New York) J Nucl Med 47:1587–1591, 2006§ , 2007 .
[24] J. Carey,et al. Release of Patients Containing Therapeutic Dosages of Iodine-131 from Hospitals , 1995 .
[25] Jyotika K. Fernandes,et al. Well Differentiated Thyroid Carcinoma: Current Treatment , 2012, Current Treatment Options in Oncology.
[26] R. Quiros,et al. To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients , 2012, Journal of oncology.
[27] A. Gafni,et al. A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors , 2008, Clinical endocrinology.
[28] S. Larson,et al. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[29] D. van Nostrand,et al. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] A. Turnbull,et al. Structural and functional development of the human foetal thyroid. , 1966, Clinical science.
[31] A. Introduction. RELEASE OF PATIENTS ADMINISTERED RADIOACTIVE MATERIALS , 1997 .
[32] P. Grigsby,et al. Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. , 2000, JAMA.
[33] A. Gafni,et al. A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors , 2008, Clinical endocrinology.